Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.247, 2000-01, pp. : 11-11
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Early interferon-β-1b of BENEFIT for MS?
Inpharma, Vol. 1, Iss. 1600, 2007-01 ,pp. :
Access to resources
Recommend
High dose interferon- -1b effective in both early and advanced MS
Inpharma, Vol. 1, Iss. 1387, 2003-01 ,pp. :
Interferon- -1b good value for money in relapsing-remitting MS
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 317, 2001-01 ,pp. :
Patients with multiple sclerosis (MS) who receive interferon (IFN)- -1a [`Avonex']
Inpharma, Vol. 1, Iss. 1330, 2002-01 ,pp. :